Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,030.20 -102.95 -0.68%
S&P 500 1,679.45 -14.42 -0.85%
Nasdaq 3,778.56 -36.46 -0.96%
Ticker Volume Price Price Delta
STOXX 50 2,902.12 -16.19 -0.55%
FTSE 100 6,449.04 +11.54 0.18%
DAX 8,597.91 -31.51 -0.37%
Ticker Volume Price Price Delta
Nikkei 14,157.20 -13.24 -0.09%
Hang Seng 23,214.40 +229.92 1.00%
S&P/ASX 200 5,234.89 +19.33 0.37%
  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Health Care Select Sector SPDR Fund

+ Add to Watchlist

XLV:US

50.7550 USD 0.3550 0.69%

As of 13:26:09 ET on 10/03/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Health Care Select Sector SPDR Fund (XLV)

Open: 51.0500 High - Low: 51.0700 - 50.4500 Primary Exchange: NYSE Arca
Volume: 4,014,240 52-Week Range: 38.4800 - 52.1900 Beta vs IXV: 0.9958

ETF Chart for XLV

No chart data available.
  • XLV:US 50.7550
  • 1D
  • 1M
  • 1Y
51.1100
Interactive XLV Chart

Previous Close

Fund Profile & Information for XLV

Health Care Select Sector SPDR Fund is an exchange-traded fund incorporated in the USA. The Fund's objective is to provide investment results that correspond to the performance of The Health Care Select Sector Index. The Index includes companies involved in health care equipment and supplies, health care providers and services, biotechnology & pharmaceuticals.

Inception Date: 1998-12-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XLV

NAV (on 2013-10-02) 51.1344
Assets (M) (on 2013-10-02) 7,568.6850
Shares out (M) 148.02
Market Cap (M) 7,496.98
% Premium -0.05
Average 52-Week % Premium 0.0000
Fund Leveraged N

Dividends for XLV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2013-09-20) 0.2129
Dividend Yield (ttm) 1.65%

Performance for XLV

1-Month +4.27% 1-Year +28.41%
3-Month +7.73% 3-Year +21.12%
Year To Date +29.83% 5-Year +13.26%
Expense Ratio 0.18

Top Fund Holdings for XLV

Filing Date: 10/02/2013
Name Position Value % of Total
Johnson & Johnson 10,766,436 939,802,198 12.431%
Pfizer Inc 25,292,852 733,745,608 9.706%
Merck & Co Inc 11,180,161 540,784,388 7.153%
Gilead Sciences Inc 5,847,795 365,019,364 4.828%
Amgen Inc 2,878,187 325,407,822 4.304%
Bristol-Myers Squibb Co 6,321,791 296,681,652 3.924%
UnitedHealth Group Inc 3,916,223 284,200,303 3.759%
AbbVie Inc 6,057,080 278,322,826 3.681%
Celgene Corp 1,571,291 245,011,406 3.241%
Biogen Idec Inc 928,341 228,585,404 3.024%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil